News | Point-of-Care Ultrasound (POCUS) | October 08, 2020

Butterfly Network Releases New Version of Point-of-Care Ultrasound Platform With Butterfly iQ+

Butterfly Network Inc. is launching its next-generation Butterfly iQ+ point-of-care-ultrasound (POCUS) technology that can turn a smartphone into a diagnostic imaging system. It offers a new needle guidance app.

Butterfly Network Inc. is launching its next-generation Butterfly iQ+ point-of-care-ultrasound (POCUS) technology that can turn a smartphone into a diagnostic imaging system. It offers a new needle guidance app.

October 8, 2020 – Butterfly Network Inc. is launching its next-generation Butterfly iQ+ point-of-care-ultrasound (POCUS) technology that can turn a smartphone into a diagnostic imaging system.

Using ultrasound-on-chip technology, the Butterfly iQ+ offers new capabilities, such as faster frame rates, Needle Viz technology, a longer battery life and improved durability. 

Butterfly’s mission is to democratize healthcare by making medical imaging accessible to everyone around the world. From underserved communities in the United States, to remote areas around the globe, 4.7 billion people lack access to medical imaging. Putting ultrasound on a chip, Butterfly was able to define a new precedent of affordability by providing a whole-body ultrasound device at $1,999, plus membership. The Butterfly iQ+ will be available for the same price. 

“Two years ago, Butterfly introduced the world's first handheld, single-probe, whole-body ultrasound system. Since then, the device has been used by tens of thousands of medical professionals across the globe with significant clinical, economic and societal impact,” said Laurent Faracci, Butterfly Network’s CEO. “We have collaborated with the Butterfly community of users to define our innovation path. The first result in that journey is the new Butterfly iQ+, a big step forward for point-of-care ultrasound, with our most advanced chip ever and a number of amazing innovations and improvements that our talented team and partners developed.”

Butterfly iQ+ features an optimized manufacturing process in partnership with TSMC, the largest and most advanced dedicated IC foundry in the world. TSMC’s MEMS (microelectromechanical systems) manufacturing technology enables the ultrasound transducer to seamlessly integrate with CMOS (complementary metal-oxide semiconductor) technology. In addition, TSMC possesses manufacturing capacity that can scale to realize Butterfly’s vision of making an ultrasound device as ubiquitous as the stethoscope for the world’s 40 million healthcare providers, the company said.

Butterfly’s innovative product has been shown to be a particularly useful tool during the global COVID-19 (SARS-CoV-2) pandemic due to its lung imaging capabilities, portability and ease of cleaning, as infection control has become increasingly important. Butterfly iQ+ brings a suite of new capabilities that make it even easier to make fast decisions at the bedside. 

“These new capabilities bring us one step closer to realizing the full potential of bedside point-of-care ultrasound as the stethoscope of the future, a true window into the body,” said Dr. John Martin, Butterfly Network’s chief medical officer. 

 

Butterfly iQ+ Offers Faster, Sharper Imaging

With patented on-chip digital micro-beamforming enabling 15% faster frame rates and 60% faster pulse repetition frequency, healthcare providers can see image details in the heart, lungs and bladder with optimized clarity. High-performance shallow imaging capabilities help support fast, confident interventional decision-making, while deep imaging capabilities in the lung and deep cardiac presets allow for sharp details. The Butterfly iQ+ can help healthcare providers save time in their diagnosis and treatment of patients, improving overall patient outcomes.

 

State-of-the-art POCUS Technology Offers New Levels of Control

The cutting-edge Needle Viz technology available on Butterfly iQ+ can provide healthcare professionals with an enhanced ability to see a needle—improving confidence for central line placements, regional nerve blocks and other guided procedures. Additionally, in just four seconds, clinicians can calculate bladder volume automatically using the AI-based Auto Bladder Volume tool, allowing faster decisions at the bedside. 

 

Hand-held Ultrasound Offers More Power and Durability 

The Butterfly iQ+ extends battery life by 20% and scanning time by 100% to help healthcare providers get through their shift. With its durable, anodized aluminum body and replaceable compression- and stomp-tested cable, the Butterfly iQ+ offers military-grade durability to withstand tough shifts, and has been tested to withstand an industry-leading 4-foot drop. This next-generation device has gone through rigorous testing to ensure shock resistance and protection from dust and water damage. 

For more information: www.butterflynetwork.com

Related Content

MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI.

MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI. Image courtesy of Exact Imaging

Feature | Prostate Cancer | January 20, 2021 | By Brian Wodlinger, Ph.D.
Historically when a patient had an elevated PSA (prostate specific antigen) test their urologist would take the next
Previously approved by FDA in the USA, MyLab X8 expands the reach of the MyLab Ultrasound Product Line with a fully featured premium imaging solution, integrating the latest technologies and delivering superior image quality without compromising workflow or efficiency.
News | Ultrasound Imaging | January 20, 2021
January 20, 2021 — Esaote North America announces that the...
Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound.

Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound. Image courtesy of UVA Health

News | Focused Ultrasound Therapy | January 08, 2021
January 8, 2021 — A scalpel-free alternative to brain surgery has the potential to benefit people with...
Ultromics will offer its artificial intelligence driven EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site. #AI #AIhealthcare #AIecho

Ultromics will offer its artificial intelligence driven EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

News | Artificial Intelligence | January 06, 2021
January 6, 2021 — The U.S.
New software-based application helps clinicians visualize breast anatomy and provides detailed characterization of lesions
News | Breast Imaging | December 17, 2020
December 17, 2020 — Hologic, Inc.
For some, COVID-19 can result in severe pneumonia or even death, while others remain purely asymptomatic. A diagnostic tool could help physicians predict if a patient with COVID-19 will worsen.

Using 14 points in the lungs, researchers looked for abnormalities and assigned each spot a score out of 3 based on its severity. Adding up all the points, they found the total lung ultrasound score was higher for those who had a worsening outcome of COVID-19. Image courtesy of Umberto Sabatini

News | Coronavirus (COVID-19) | December 11, 2020
December 11, 2020 — For some, COVID-19 can resul
An MR image of a patient in their early 20s shows nerve injury (highlighted in yellow) of the left brachial plexus in the neck. The patient experienced left arm weakness and pain after recovering from COVID-19 respiratory illness, which prompted them to see their primary care physician. As a result of the MRI findings, the patient was referred to the COVID-19 neurology clinic for treatment. Image courtesy of Northwestern University

An MR image of a patient in their early 20s shows nerve injury (highlighted in yellow) of the left brachial plexus in the neck. The patient experienced left arm weakness and pain after recovering from COVID-19 respiratory illness, which prompted them to see their primary care physician. As a result of the MRI findings, the patient was referred to the COVID-19 neurology clinic for treatment. Image courtesy of Northwestern University

News | Coronavirus (COVID-19) | December 08, 2020
December 8, 2020 — After recovering from COVID-19
Samsung to highlight its medical imaging portfolio with its latest radiology innovations in ultrasound, digital radiography and mobile computed tomography
News | Radiology Imaging | December 02, 2020
December 2, 2020 — Samsung Electronics Co., Ltd.